That’s a very nice study from the Japanese community, but it’s an observational study. So that means that the results cannot be applied instantly to the community. But we have to say that they want to check how the ctDNA works in the prognostic and predictive way. So they find out the data that they have is that supports that ctDNA is a good biomarker in the prognostic way, but not in the predictive way...
That’s a very nice study from the Japanese community, but it’s an observational study. So that means that the results cannot be applied instantly to the community. But we have to say that they want to check how the ctDNA works in the prognostic and predictive way. So they find out the data that they have is that supports that ctDNA is a good biomarker in the prognostic way, but not in the predictive way. So it needs more trials to figure out how can ctDNA help us to escalate or deescalate a treatment.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.